Brain-Derived Plasma pTau217 Better Predicted Near-Term Amyloid PET Progression
TL;DR: A 2026 ADNI analysis posted to medRxiv found that brain-derived plasma pTau217 better predicted near-term amyloid positron emission tomography (PET) positivity than total plasma pTau217 in cognitively unimpaired amyloid-negative participants. Key Findings 1,427 ADNI participants: Plasma NULISAseq biomarkers were measured across the broader Alzheimer’s Disease Neuroimaging Initiative sample. 529 cognitively unimpaired: The main prognostic …
